ABSTRACT
Purpose:
Chronic inflammation in the liver is a key trigger for liver injury and fibrosis in various liver diseases. Given the anti-inflammatory and antioxidant effects of Saffron, this study aimed to investigate the pharmacological effects of Saffron on hepatic inflammation and fibrosis.
Methods:
The mice model of hepatic fibrosis was constructed using CCl4, and Saffron was administered at low (10 mg/kg) and high (20 mg/kg) doses by gavage. Then, the changes in liver function, liver inflammation and fibrosis markers were evaluated. The effects and mechanisms of Saffron on hepatic stellate cells were further investigated in in-vitro experiments.
Results:
Saffron improved liver function, reduced liver inflammation and attenuated liver fibrosis in a dose-dependent manner in hepatic fibrosis mice. Furthermore, Western blotting showed that Saffron significantly inhibited JAK/STAT3 phosphorylation in fibrotic livers.
Conclusions:
Saffron can attenuate liver fibrosis by inhibiting the JAK/STAT3 pathway and the activation of hepatic stellate cell, providing a theoretical basis for the development of new anti-fibrotic drugs.
Key words
Liver Cirrhosis; Crocus; Inflammation
Thumbnail
Thumbnail
Thumbnail
TGF: transforming growth factor; *p < 0.05; **p < 0.01; ***p < 0.001. Source: Elaborated by the authors.
ALT: alanine transaminase; AST: aspartate transaminase; IL: interleukin; TGF: transforming growth factor; *p < 0.05; **p < 0.01; ***p < 0.001.Source: Elaborated by the authors.
GAPDH: glyceraldehyde 3-phosphate dehydrogenase; TGF: transforming growth factor; *p < 0.05; **p < 0.01; ***p < 0.001. Source:Elaborated by the authors.